These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
25. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Bender JG, Unverzagt K, Walker DE, Lee W, Smith S, Williams S, Van Epps DE. Clin Immunol Immunopathol; 1994 Jan; 70(1):10-8. PubMed ID: 7505211 [Abstract] [Full Text] [Related]
29. [In vitro effects of hematopoietic growth factors on CD34+ cell from patients with myelodysplastic syndromes]. Yang X, Gu X, Pei X, Zhu L. Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):354-7. PubMed ID: 15624331 [Abstract] [Full Text] [Related]
31. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Benito AI, Bryant E, Loken MR, Sale GE, Nash RA, John Gass M, Deeg HJ. Leuk Res; 2003 May; 27(5):425-36. PubMed ID: 12620294 [Abstract] [Full Text] [Related]
32. Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores. Reis-Alves SC, Traina F, Harada G, Campos PM, Saad ST, Metze K, Lorand-Metze I. PLoS One; 2013 May; 8(12):e81048. PubMed ID: 24324660 [Abstract] [Full Text] [Related]
34. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Saitoh K, Miura I, Takahashi N, Miura AB. Blood; 1998 Oct 15; 92(8):2886-92. PubMed ID: 9763574 [Abstract] [Full Text] [Related]
36. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J. Blood Cells; 1994 Oct 15; 20(2-3):411-23. PubMed ID: 7538347 [Abstract] [Full Text] [Related]
37. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1994 Aug 15; 22(9):919-23. PubMed ID: 7520394 [Abstract] [Full Text] [Related]
38. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley P, de Hemptinne D, Stryckmans P. Stem Cells; 1995 May 15; 13(3):281-8. PubMed ID: 7613494 [Abstract] [Full Text] [Related]